NASDAQ:TNDM

Tandem Diabetes Care Stock News

etoro logo Buy TNDM
*Your capital is at risk
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026

Tandem Diabetes Valuation: Is 1.1x Sales a Buy?

12:26pm, Wednesday, 03'rd Jun 2026
TNDM trades near 1.1x forward sales as it shifts to pharmacy pay-as-you-go and expands Europe, with a $21 target tied to 1.3x sales.
Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts more U.S. pump starts to pay-as-you-go pharmacy.
On May 28, 2026, Tandem Diabetes Care Inc (TNDM) shares experienced a notable rise of 12.9%, bringing the current price to $16.74. The stock has fluctuated with
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
Tandem Diabetes beats Q1 revenue and earnings estimates as gross margin expands, but shares decline 23.6% after the results announcement.
Tandem Diabetes Care, Inc. (TNDM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Tandem Diabetes Care (TNDM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earning
Tandem Diabetes Care, Inc. (TNDM) Q1 2026 Earnings Call Transcript

Tandem Diabetes Care Q1 Earnings Call Highlights

01:07am, Saturday, 09'th May 2026
Tandem Diabetes Care NASDAQ: TNDM reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward ph
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to a loss of $0.67 per share a year ago.
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.
On April 13, 2026, Tandem Diabetes Care Inc (TNDM) shares rose 4.8% today, bringing the current price to $20.10. Despite today's increase, the stock has fluctua
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial m
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE